Paper No. ____
`Filed: December 14, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC, MYLAN PHARMACEUTICALS
`INC., and MYLAN INC.,
`Petitioner
`v.
`
` SENJU PHARMACEUTICAL CO., LTD., BAUCSH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`_________________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed: December 14, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC, MYLAN PHARMACEUTICALS
`INC., and MYLAN INC.,
`Petitioner
`v.
`
` SENJU PHARMACEUTICAL CO., LTD., BAUCSH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`_________________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`Further to 37 C.F.R. § 42.63(e), Patent Owner Senju Pharmaceutical Co.,
`
`Ltd., hereby submits a current listing of Senju Exhibits to counsel for Petitioner
`
`InnoPharma Licensing, Inc., InnoPharma Licensing LLC, InnoPharma Inc.,
`
`InnoPharma LLC, Mylan Pharmaceuticals Inc., and Mylan Inc..
`
`Exhibits
`Exhibit 2001
`
`Exhibit 2002
`
`Exhibit 2003
`
`Exhibit 2004
`
`Exhibit 2005
`
`Exhibit 2006
`
`Exhibit 2007
`
`Exhibit 2008
`
`Exhibit 2009
`
`Exhibit 2010
`
`Exhibit 2011
`
`
`
`Description
`Transcript of Teleconference with the Board, dated April
`15, 2015.
`U.S. Patent No. 8,669,290 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-
`bromobenzoyl)phenylacetic acid.”
`U.S. Patent No. 8,754,131 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-
`bromobenzoyl)phenylacetic acid.”
`U.S. Patent No. 8,871,813 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-
`bromobenzoyl)phenylacetic acid.”
`U.S. Patent No. 8,927,606 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-
`bromobenzoyl)phenylacetic acid.”
`InnoPharma’s Paragraph IV Notice Letter dated September
`19, 2014.
`InnoPharma’s Paragraph IV Notice Letter dated October 30,
`2014.
`InnoPharma’s Paragraph IV Notice Letter dated March 27,
`2015.
`Complaint, Senju Pharm. Co., Ltd. et al. v. InnoPharma
`Licensing, Inc. et al., No. 14-cv-06893 (D.N.J. Nov. 3,
`2014), ECF No. 1.
`Complaint, Senju Pharm. Co., Ltd. et al. v. InnoPharma
`Licensing, Inc. et al., No.15-cv-03240 (D.N.J. May 8,
`2015), ECF No. 1.
`Consolidated scheduling order, Senju Pharm. Co., Ltd. et al.
`v. InnoPharma Licensing, Inc. et al., No. 14-cv-06893
`
`2
`
`
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`(D.N.J. April 16, 2015), ECF No. 30.
`Amended scheduling order, Senju Pharm. Co., Ltd. et al. v.
`Lupin, Ltd. et al., No. 14-cv-00667 (D.N.J. Feb. 27, 2015),
`ECF No. 63.
`Prolensa® (bromfenac ophthalmic solution 0.07%)
`Prescribing Information.
`U.S. Patent No. 5,630,793 to Rowe, “Aqueous Ophthalmic
`Sprays.”
`Press Release by Bausch + Lomb, dated April 8, 2013,
`entitled “Bausch + Lomb Receives FDA Approval for
`Prolensa™ (bromfenac ophthalmic solution) 0.07%.”
`Lupin’s Paragraph IV Notice Letter dated March 13, 2014.
`Metrics’ Paragraph IV Notice Letter dated June 26, 2014.
`Paddock’s Paragraph IV Notice Letter dated December 15,
`2014.
`Apotex’s Paragraph IV Notice Letter dated December 10,
`2014.
`Masson et al., Stabilisation of ionic drugs through
`complexation with non-ionic and ionic cyclodextrins, INT’L
`JOURNAL OF PHARMACEUTICS 164 (1998).
`Loftsson et al., Pharmaceutical Applications of
`Cyclodextrins, JOURNAL OF PHARMACEUTICAL
`SCIENCES 85:10 (1996).
`HSBC Global Research Lupin Company Report, February
`3, 2014, http://www.lupin.com/pdf/14/20140203%20-
`%20Lupin%203QFY14%20-%20HSBC.pdf
`APOTEX ALL PRODUCTS,
`https://www.apotex.com/us/en/products/search.asp?qt=All&
`qs=&t=All%20Products.
`Consent judgment, Senju Pharm. Co., Ltd. et al. v. Apotex
`Inc. et al., No. 15-cv-00336 (D.N.J. May 18, 2015), ECF
`No. 26.
`U.S. Patent No. 5,856,345 to Doi et al., “Method for
`Stabilizing Pranoprofen and Stable Liquid Preparation of
`Pranoprofen.”
`Xibrom® Prescribing Information.
`
`3
`
`Exhibit 2012
`
`Exhibit 2013
`
`Exhibit 2014
`
`Exhibit 2015
`
`Exhibit 2016
`Exhibit 2017
`Exhibit 2018
`
`Exhibit 2019
`
`Exhibit 2020
`
`Exhibit 2021
`
`Exhibit 2022
`
`Exhibit 2023
`
`Exhibit 2024
`
`Exhibit 2025
`
`Exhibit 2026
`
`
`
`
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`Bromday® Prescribing Information.
`Drugs@FDA, Listing of FDA-approved bromfenac
`ophthalmic solution 0.09% products,
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index
`.cfm?fuseaction=Search.Overview&DrugName=BROMFE
`NAC%20SODIUM.
`Sheryl Gay Stolberg, New Painkiller is Withdrawn After 4
`Deaths, N.Y. Times, Jun. 23, 1998.
`Baklayan et al., The ocular distribution of 14C-labeled
`bromfenac ophthalmic solution 0.07% in a rabbit model,
`CLINICAL OPHTHAMOLOGY 2014:8, 1717-1724 (2014).
`Reserved
`Reserved
`Reserved
`Reserved
`Transcript of Teleconference with the Board, dated
`December 11, 2015
`
`Exhibit 2027
`Exhibit 2028
`
`Exhibit 2029
`
`Exhibit 2030
`
`Exhibit 2031
`Exhibit 2032
`Exhibit 2033
`Exhibit 2034
`Exhibit 2035
`
`
`
`Dated: December 14, 2015
`
`
`
`Respectfully submitted,
`
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`Finnegan, Henderson, Farabow, Garrett
` & Dunner, L.L.P.
`901 New York Ave. NW
`Washington, DC 20001-4413
`
`Counsel for Patent Owner
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Updated Exhibit List and Exhibit 2035 were served on December 14,
`
`2015, via email directed to counsel of record for the Petitioner at the following:
`
`Jitendra Malik
`jitty.malik@alston.com
`
`Bryan Skelton
`bryan.skelton@alston.com
`
`Lance Soderstrom
`lance.soderstrom@alston.com
`
`Hidetada James Abe
`James.abe@alston.com
`
`
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Case Manager
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`
`
`5
`
`
`Date: December 14, 2015
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
